Stanford Initiative Leverages AI To Robustly Transform Mental Health Research And Therapy
In today's column, I explore the latest efforts to transform mental health research and therapy into being less subjective and more objective in its ongoing pursuits.
This kind of transformation is especially spurred via the use of advanced AI, including leveraging deep learning (DL), machine learning (ML), artificial neural networks (ANN), generative AI, and large language models (LLMs). It is a vital pursuit well worth undertaking. Expectations are strong that great results and new insights will be gleaned accordingly.
Let's talk about it.
This analysis of AI breakthroughs is part of my ongoing Forbes column coverage on the latest in AI, including identifying and explaining various impactful AI complexities (see the link here).
As a quick background, I've been extensively covering and analyzing a myriad of facets regarding the advent of modern-era AI that produces mental health advice and performs AI-driven therapy. This rising use of AI has principally been spurred by the evolving advances and widespread adoption of generative AI. For a quick summary of some of my posted columns on this evolving topic, see the link here, which briefly recaps about forty of the over one hundred column postings that I've made on the subject.
There is little doubt that this is a rapidly developing field and that there are tremendous upsides to be had, but at the same time, regrettably, hidden risks and outright gotchas come into these endeavors too. I frequently speak up about these pressing matters, including in an appearance last year on an episode of CBS 60 Minutes, see the link here.
If you are new to the topic of AI for mental health, you might want to consider reading my recent analysis that also recounts a highly innovative initiative at the Stanford University Department of Psychiatry and Behavioral Sciences called AI4MH, see the link here. Indeed, today's discussion is substantively shaped around a recent seminar conducted by AI4MH.
Let's begin with a cursory unpacking of what is generally thought of as a type of rivalry or balance amid being subjective versus objective.
The conceptualization of 'objective' consists of a quality or property intended to convey that there are hard facts, proven principles and precepts, clear-cut observations, reproducible results, and other highly tangible systemic elements at play. In contrast, 'subjective' is characterized as largely speculative, sentiment-based, open to interpretation, and otherwise less ironclad.
Where does the consideration of subjective vs. objective often arise?
You might be surprised to know that the question of subjective versus objective has a longstanding root in two fields of endeavor, namely psychology and physics. Yes, it turns out that psychology and physics have historically been domains that richly illuminate the dialogue regarding subjective versus objective. The general sense is that people perceive physics as tilted more toward the objective and less toward the subjective, while the perception of psychology is that it is a field angled toward the subjective side more so than the objective.
Turn back the clock to the 1890s, in which the famed Danish professor Harald Hoffding made these notable points about psychology and physics (source: 'Outlines of Psychology' by Harald Hoffding, London Macmillan, 1891):
You might notice the rather stunning point that psychology and physics are themselves inclusive of everything that could potentially be the subject of human research. That's amazingly alluring to those in the psychology and physics fields, while perhaps not quite as affable for all other domains.
In any case, on the thorny matter of subjective versus objective in the psychology realm, we can recall Pavlov's remarks made in 1930:
Pavlov's comments reflect a longstanding aspiration of the field of psychology to ascertain and verify bona fide means to augment the subjective aspects of mental health analysis with more exacting objective measures and precepts.
The final word on this goes to Albert Einstein as to the heady matter:
It's always an uphill battle to refute remarks made by Einstein, so let's take them as they are.
Shifting gears, the topic of psychology and the challenging properties of subjective vs. objective was a major theme during a recent seminar undertaken by Stanford University on May 28, 2025, at the Stanford campus.
Conducted by the initiative known as AI4MH (Artificial Intelligence for Mental Health), see the link here, within the Stanford School of Medicine, Department of Psychiatry and Behavioral Sciences, the session was entitled 'Insights from AI4MH Faculty: Transforming Mental Health Research with AI' and a video recording of the session can be found at the link here.
The moderator and the three speakers consisted of:
I attended the session and will provide a recap and analysis here. In addition, I opted to look at various research papers by the speakers. I encompass selected aspects from the papers to further whet your appetite for learning more about the weighty insights provided during the seminar and based on their respective in-depth research studies.
I'll proceed next in the same sequence as occurred during the seminar, covering each speaker one at a time, and then offer some concluding thoughts.
The human brain consists of around 86 billion neurons and approximately 100 trillion synapses. This elaborate organ in our noggin is often referred to in the AI field as the said-to-be wetware of humans. That's a cheeky sendoff of computer-based hardware and software.
Somehow, in ways that we still aren't quite sure, the human brain or wetware gives rise to our minds and our ability to think. In turn, we are guided in what we do and how we act via the miracle of what's happening in our minds. For my related discussion about the Theory of Mind (ToM) and its relationship to the AI realm, see the link here.
In the presentation by Dr. Kaustubh Supekar, he keenly pointed out that the brain-mind indubitably is the source of our mental health and ought to be closely studied when trying to ascertain the causes of mental disorders. He and his team are using AI to derive brain fingerprints that can be associated with mental disorders.
It's quite exciting to envision that we could eventually end up with a tight mapping between the inner workings of the brain-mind and how mental disorders manifest within the brain-mind. Imagine the incredible possibilities of anticipating, remedying, or at least aiding those incurring mental disorders.
In case you aren't familiar with the formal definition of what mental disorders consist of, I covered the DSM-5 guidelines in a posting on AI-driven therapy using DSM-5, see the link here, and included this definition from the well-known manual:
DSM-5 is a widely accepted standard and is an acronym for the Diagnostic and Statistical Manual of Mental Disorders fifth edition, which is promulgated by the American Psychiatric Association (APA). The DSM-5 guidebook or manual serves as a venerated professional reference for practicing mental health professionals.
In a recent research article that Dr. Kaustubh Supekar was the lead author of, entitled 'Robust And Replicable Functional Brain Signatures Of 22q11.2 Deletion Syndrome And Associated Psychosis: A Deep Neural Network-Based Multi-Cohort Study' by Kaustubh Supekar, Carlo de los Angeles, Sikanth Ryali, Leila Kushan, Charlie Schleifer, Gabriela Repetto, Nicolas Crossley, Tony Simon, Carrie Bearden, and Vinod Meno, Molecular Psychiatry, April 2024, these salient points were made (excerpts):
The study aimed to find relationships between those having a particular chromosomal omission, known as DiGeorge syndrome or technically as 22q11.2 deletion syndrome (DS), and linking the brain patterns of those individuals to common psychosis symptoms. The brain-related data was examined via the use of an AI-based artificial neural network (a specialized version involving space-time or spatiotemporal analyses underlying the data, referred to as stDNN).
This and other such studies are significant steps in the erstwhile direction of mapping brain-mind formulations to the nature of mental disorders.
Faithful readers might recall my prediction that ambient intelligence (AmI) would be a rapidly expanding field and will dramatically inevitably change the nature of our lives, see the link here.
What is ambient intelligence?
Simply stated, it is a mishmash term depicting the use of AI to bring together data from electronic devices and do so with a focus on detecting and reacting to human presence. This catchphrase got its start in the 1990s when it was considered state-of-the-art to have mobile devices and the Internet of Things (IoT) was gaining prominence. It is a crucial aspect of ubiquitous computing.
Ambient intelligence has made strong strides due to advances in AI and advances in ubiquitous technologies. Costs are getting lower and lower. Embedded devices are here and there, along with the devices seemingly invisible to those within their scope. The AI enables adaptability and personalization.
In the second presentation of the AI4MH seminar, Dr. Ehsan Adeli notably pointed out that we can make use of exhibited behaviors to try and aid the detection and mitigation of mental health issues.
But how can we capture exhibited behavior?
One strident answer is to lean into ambient intelligence.
In a research article that he served as a co-author, entitled 'Ethical Issues In Using Ambient Intelligence In Healthcare Settings' by Nicole Martinez-Martin, Zelun Luo, Amit Kaushal, Ehsan Adeli, Albert Haque, Sara S Kelly, Sarah Wieten, Mildred K Cho, David Magnus, Li Fei-Fei, Kevin Schulman, and Arnold Milstein, Lancet Digital Health, December 2020, these salient points were made (excerpts):
The idea is that by observing the exhibited behavior of a person, we can potentially link this to their mental health status.
Furthermore, via the appropriate use of AI, the AI might be able to detect when someone is having mental health difficulties or perhaps incurring an actual mental health disorder. The AI could in turn notify clinicians or others, including the person themselves, as suitably determined.
In a sense, this opens the door to undertaking continuous assessment of neuropsychiatric symptoms (NPS). Of course, as directly noted by Dr. Ehsan Adeli, the enabling of AmI for this purpose brings with it the importance of considering aspects of privacy and other AI ethics and patient ethics caveats underlying when to best use these growing capabilities.
Being evidence-based is a hot topic, aptly so.
The trend toward evidence-based medicine and healthcare has been ongoing and aims to improve both research and practice, doing so in a classic less subjective, and more objective systematic way. The American Psychological Association (APA) defines evidence-based practice in psychology (EBPP) as 'the integration of the best available research with clinical expertise in the context of patient characteristics, culture, and preferences.'
The third speaker in the AI4MH seminar was Dr. Shannon Wiltsey Stirman, a top researcher with a focus on how to facilitate the high-quality delivery of evidence-based psychosocial (EBPs) interventions. Among her research work is a framework for identifying and classifying adaptations made to EBPs in routine care.
On the matter of frameworks, Dr. Stirman's presentation included a discussion about a newly formulated framework associated with evaluating AI-based mental health apps. The innovative and well-needed framework had been devised with several of her fellow researchers. In a co-authored paper entitled 'Readiness Evaluation for Artificial Intelligence-Mental Health Deployment and Implementation (READI): A Review and Proposed Framework' by Elizabeth Stade, Johannes Eichstaedt, Jane Kim, and Shannon Wiltsey Stirman, Technology, Mind, and Behavior, March 2025, these salient points were made (excerpts):
Longtime readers know that I have been calling for an assessment framework like this for quite a while.
For example, when OpenAI first allowed ChatGPT users to craft customized GPTs, there was a sudden surge in GPT-based applets that purportedly performed mental health therapy via the use of ChatGPT. In my review of those GPTs, I pointed out that many were not only vacuous, but they were at times dangerous in the sense that the advice being dispensed by these wantonly shaped ChatGPT applets was erroneous and misguided (see my extensive coverage at the link here and the link here).
I have also repeatedly applauded the FTC for going after those who tout false claims about their AI for mental health apps (see my indication at the link here). Just about anyone can readily stand up a generative AI app that they claim is suitable for mental health therapy. They might have zero experience, zero training, and otherwise be completely absent from any credentials associated with a mental health professional.
Meanwhile, consumers are at a loss to know which mental health apps are prudent and useful and which ones are problematic and ought to be avoided. It is for this reason that I have sought a kind of Consumer Reports scoring that might be used to differentiate AI mental health apps (see my discussion at the link here).
The new READI framework is a substantial step in that profoundly needed direction.
Moving the needle on the subjective vs. objective preponderance in psychology is going to take earnest and undeterred energy and attention.
Newbie researchers especially are encouraged to pursue these novel efforts. Seasoned researchers might consider adjusting their usual methods to also incorporate AI, when suitable. The use of AI can be a handy tool and demonstrative aid. I've delineated the many ways that AI has already inspired and assisted psychology, and likewise, how psychology has aided and inspired advances in AI, see the link here for that discussion.
There is a great deal at stake in terms of transforming psychology and the behavioral sciences as far forward as we can aim to achieve. Besides bolstering mental health, which certainly is crucial and laudable, Charles Darwin made an even grander point in his 'On the Origin of Species by Means of Natural Selection' in 1859:
You see, the stakes also include revealing the origins of humankind and our storied history.
Boom, drop the mic.
Some might say it is ironic that AI as a computing machine would potentially have a hand in the discovery of that origin, but it isn't that far-fetched since AI is in fact made by the hand of humanity. It's our self-devised tool in an expanding toolkit to understand the world.
And which gladly includes two very favored domains, e.g., the close and dear cousins of psychology and physics.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
How Advisors Can Avoid Becoming Over-Reliant on AI
Apparently there's no AI in team. Artificial intelligence is being hailed as a key element of the fourth industrial revolution, and new tools are now assisting financial advisors with taking notes, drafting emails, and brainstorming thought leadership content. In fact, the vast majority of advisors said generative AI helped their practices, according to a survey earlier this year. But AI isn't a silver bullet. It lacks emotional intelligence and a human touch. Advisors risk damaging client relationships if they become too reliant on automation — even for routine tasks. 'AI is poor at empathy so far,' said Adrian Johnstone, CEO of the CRM platform Practifi. 'Advisors need to recognize where the personal connection is most powerful, and use AI to automate and alleviate the lesser functions.' READ ALSO: What the GENIUS Act Means for Stablecoins and Advisors and Why UBS Is the Only Wirehouse to Allow Podcasting Today, most advisors use AI to boost meeting efficiency and streamline workflows. Ideally, this frees up more time to spend with clients, but misusing these tools can backfire. 'The common refrain of disaffected clients is: 'I pay you to understand me, my goals, and my fears, not to outsource me to a machine,'' Johnstone said. Wealth management is built on bespoke service, but AI hasn't yet learned to fully adapt to individual client needs and goals. While tools that draft emails and website content are improving, the output still reads 'hollow and generic,' Johnstone warned. Use it or Lose it. Client-facing AI tools can be 'extremely risky' because they can't interpret emotional undertones of client's concerns, said Rafael Loureiro, CEO of an estate planning platform. Still, AI can be useful for quick, factual tasks. 'If it's midnight on a Sunday and a client asks, 'What was my marginal tax rate last year?' that's a perfect use case,' Loureiro said. 'It's not doing financial planning, but answering factual questions.' Everything in Moderation. This isn't the first time new tech or strategies meant to disrupt the wealth management industry have wound up causing trouble for advisors and their clients. Will Trout, director at Datos Insights, pointed to the 2008 financial crisis as a warning. 'Firms that over-relied on risk models without human oversight suffered catastrophic losses,' he told Advisor Upside. This post first appeared on The Daily Upside. To receive financial advisor news, market insights, and practice management essentials, subscribe to our free Advisor Upside newsletter. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
36 minutes ago
- Yahoo
INICIO™ multi-slide door delivers expansive views, effortless movement, and design-driven flexibility
*Architect-driven design meets American performance in the newest innovation from BMD Manufacturing.* GALT, Calif., June 20, 2025 /PRNewswire/ -- INICIO™, a brand of BMD Manufacturing, has launched its new multi-slide door system, a precision-engineered solution for indoor-outdoor living in modern residential design. Inspired by European minimalism and manufactured to meet U.S. performance standards, this aluminum multi-slide system combines expansive glass, smooth movement, and design flexibility for high-end applications. As the "bringing the outdoors in" trend continues to shape residential architecture, design professionals are seeking wider openings that welcome light, air, and uninterrupted views. The INICIO multi-slide door is engineered to meet those priorities with clean profiles and refined operation. Architectural simplicity, built for impact The system features narrow stiles and rails, a flush sill option, and a quiet European carriage system for smooth panel movement. Individual panels can reach up to 70 square feet—up to 12 feet in height and up to 8 feet in width—with unlimited tracks available for large-format openings. Custom colors. Split finishes. Maximum flexibility. INICIO offers standard finishes in clear anodized and black anodized, both delivering lasting architectural appeal. For expanded design control, over 200 powder coat color options are available, all finished to meet AAMA 2604 standards. The system supports split-finish capability, allowing different colors on the interior and exterior of each door. This gives architects the freedom to match interior palettes while coordinating with an independent exterior design. Custom color matching is also available on request. High-performance glass by Saint-Gobain INICIO multi-slide doors use high-efficiency Low E3 glass manufactured by Saint-Gobain. Two performance configurations are available: Low E3 – CLX 61/29: Ideal for hot climates or strong solar exposure. Offers lower solar heat gain and higher exterior reflectivity. Low E3 – CLX 70/33: Allows more daylight transmission while maintaining thermal performance. A strong option for balanced natural lighting. Both glass options feature argon gas fill and triple silver Low E coatings for energy efficiency, UV protection, and clarity. Secure hardware and integrated screen options Hardware options include AmesburyTruth ® and HOPPE® systems with flush handles and optional keyed exterior access, available in silver, black, or white. Centor ® retractable screens are available to enhance ventilation and comfort without compromising sightlines. Warranty and availability INICIO multi-slide doors are backed by a 10-10-5 warranty: 10 years on finish, 10 years on glass, and 5 years on hardware. The product is now available through authorized dealers. To explore configurations, finish options, and project inspiration, visit Media Contact: Michael Anderson Marketing Manager BMD Manufacturing 209-915-3174 marketing@ **About BMD, Inc.** INICIO is part of BMD Manufacturing, a division of BMD, Inc. Headquartered in Galt, California, BMD, Inc. operates more than 20 businesses and locations nationwide and represents a portfolio of over 30 brands. BMD Manufacturing includes INICIO Windows + Doors (steel and aluminum exterior windows and doors), Glenview Doors (high-design entry and interior doors), and Carriage House Door Company (custom wood and steel garage doors). Together, these brands serve architects, builders, and design professionals seeking performance-driven, design-forward solutions for the residential market. View original content to download multimedia: SOURCE INICIO Windows + Doors Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
41 minutes ago
- Yahoo
Penumbra may gain market share in peripheral embolisation coils with Ruby XL
Penumbra has announced US Food and Drug Administration approval for its Ruby XL system, which includes three coils: the Ruby XL, the POD XL and the Packing Coil XL. The Ruby XL coil is a device used in vascular embolisation, a procedure to block or close off blood vessels, and can be used to frame large aneurysms, while the POD XL is designed for use in high-flow vessels and the Packing Coil XL is designed to adjust to the shape of any vessel up to 70cm in length. All Ruby XL system coils can be delivered through a 0.035-inch diagnostic catheter. The system is expected to enable Penumbra to increase its market share in peripheral embolisation coils, according to leading data and analytics company GlobalData. According to GlobalData's US healthcare facility invoicing database, Penumbra currently holds the majority market share for peripheral embolisation coils. Its new coil system allows for peripheral embolisation procedures to be done on a wider range of aneurysm sizes and in longer vessels. If the Ruby XL coil is widely adopted by physicians, Penumbra may be able to capture half the entire market. The approval of the new coil could put a bigger gap between Penumbra and its competitors in the market. Physicians may choose Ruby XL coils for their procedures in order to gain better control of large aneurysms. The Ruby XL system may come with cost savings for consumers as it delivers more volume per coil than other available coils. The average selling price (ASP) of these coils ranges from approximately $900 to $2,000. Already in the middle of this range with its current coils, Penumbra has a competitive advantage for new products. If they come in with a competitive ASP, Penumbra may displace competitor coils for relevant procedures. Penumbra stands to maintain its market lead and possibly increase its market share as the purchasing of the Ruby XL system begins. GlobalData will continue to monitor market trends as purchasing picks up. It is expected that facilities will begin purchasing these coils in June 2025. "Penumbra may gain market share in peripheral embolisation coils with Ruby XL" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
